the aid library

LIST OPTIONS

Filter

8190

Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19
recommended

World Health Organization (WHO); Unicef (2020) CC

Updated Interim guidance 29 July 2020 The provision of safe water, sanitation and waste management and hygienic conditions is essential for preventing and for protecting human health during all infectious disease outbreaks, including of coronavirus disease 2019 (COVID-19). Ensuring evidenced-based ... more

Download (358)

View PDF (555)

Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation

European Monitoring Centre for Drugs and Drug Addiction (2018) C2

An update from the EU Early Warning System

Download (622)

View PDF (537)

WHO report on cancer: setting priorities, investing wisely and providing care for all

World Health Organization WHO (2020) C1

Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report. In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available... more

External Link

Status Report on the Sexual and Reproductive Health of Adolescents Living in Urban Slums in Kenya

Donatien Beguy 1 , Joyce Mumah , Salome Wawire , Kanyiva Muindi 1, Lindsey Gottschalk and Caroline W. Kabiru UKAID, APHRC, Population Counc (2013) C1

TEP UP Technical Working Paper

Download (264)

View PDF (478)

Ukraine: Public Health Situation Analysis (PHSA) - Long-form

Health Cluster, WHO (2022) C_WHO

(Last Update: July 2022)

Download (802)

View PDF (1890)

Australian Guidelines for the Prevention of Infection in Health Care 2010

Australian Commission on Safety and Quality in Health Care (ACSQHC) (2010) C1

An Update will be published in late 2018

Download (293)

View PDF (434)

The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin

World Health Organization (2016) C_WHO

Policy update.

Download (293)

View PDF (300)

Evaluation of Child Friendly Spaces - Tools and guidance for monitoring and evaluating CFS

UNICEF (2014) CC

Child friendly spaces (CFS) are safe spaces where communities create nurturing environments in which children can access free and structured play and learning activities. CFS, also commonly referred to as Child Centred Spaces or Safe Spaces for Children, may provide educational and psychosocial... more

Download (379)

View PDF (699)

Monsoon Emergency Preparedness Response - Cox’s Bazar Rohingya Refugee Crisis (22 - 27 June 2018)

Inter Sector Coordination Group (ISCG) (2018) C1

Update - 27 June 2018
During the reporting week, the monsoon rains brought 252 mm of rainfall compared to 95 mm during the previous week. The downpour caused 65% of the week’s weather-related incidents (i.e. landslides, wind-storms and floods). Three rain gauges were installed in Chakmarkul (... more

Download (304)

View PDF (274)

Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for key populations

C. Beyrer; A. Kamarulzaman; E. Aaraj; et al. World Health Organization WHO (2016) CC

2016 Update Key population

Download (1576)

View PDF (2490)

Paediatric emergency triage, assessment and treatment: care of critically-ill children

World Health Organization WHO (2016) C_WHO

Updated Guideline. The Emergency Triage Assessment and Treatment (ETAT) guidelines provide guidance on the most common emergency conditions in children presenting at the health facility. These include but are not limited to airway obstruction and other breathing problems; circulatory impairment or ... more

Download (208)

View PDF (493)

How can social protection reduce adolescent HIV-Risk?

Cluver, L, Orkin, M, Meinck, F, Boyes, M, & Sherr, L Unicef; The Coalition for Children Affected by AIDS; European Research Council; et al. (2016)

(2016) ‘Structural Drivers and social protection: mechanisms of HIV risk and HIV prevention for South African adolescents’. JIAS, 2016, 19(1):20646. http://dx.doi.org/10.7448/IAS.19.1.20646. Social protection and HIV: Research implications for policy - 1 of 6

Download (455)

View PDF (688)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (320)

View PDF (357)

Preschool PTSD Treatment

Scheeringa, M.S., Amaya-Jackson, L. & Cohen, J. (2010) C2

Version 1.7 Updated October 14, 2010 | Preschool PTSD Treatment (PPT) is a theory-driven, manualized protocol based on cognitive-behavioral therapy (CBT) with modifications for young children. Some of these modifications involve parent-child relationship dynamics that are salient for this age grou... more

Download (288)

View PDF (261)

Guidelines for Case-Finding, Diagnosis, and Public Health Response in South Africa

Bham, A.; J. Bhiman, F. Bongweni et al. National Department of Health South Africa (2020) CC

In the light of the transmissibility of coronaviruses, and the global experience with MERS-CoV (ongoing) and SARS in 2003 which were also caused by coronaviruses, South African authorities have compiled this guideline document to support surveillance, case finding, diagnosis, management and public h... more

Download (417)

View PDF (578)

Governance for the validation of elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus:

World Health Organization WHO (2022) C_WHO

An overview of validation structures and responsibilities at national, regional and global levels. This governance document supplements the global guidance document. Validation of elimination requires rigorous assessment at the national, regional and global levels of the impact and process indicato... more

Download (797)

View PDF (1030)

HIV Testing and Counselling (HTC) Plan, Malawi

Government of Malawi, Ministry of Health (2015) C1

The 5 years plan to scale up HIV Testing and Counselling Services in Malawi 2006-2010

Download (340)

View PDF (548)

Handbook for the Management of Public Health Events in Air Transport

World Health Organization WHO (2016) C_WHO

Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl... more

Download (177)

View PDF (128)

Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 2: establishing stakeholder engagement and governance mechanisms 2022

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO

To maintain a structured and well-organized implementation plan it is important to have a lead agency or sector. The ministry of health or a similar authority in government will be critical in facilitating development and implementation of the multisectoral action plan.

Download (708)

View PDF (820)

Water Safety Plans - Training package. Participant workbook

World Health Organization (WHO), International Water Association (IWA) (2012) C_WHO

The workshop is structured around 13 learning modules. The first module (Introduction) gives an overview of WSPs. The last module (Module 12) introduces participants to the quality assurance tool for WSPs (WHO & IWA, 2012). Modules 1–11 relate explicitly to the WSP manual produced by IWA and WHO (... more

Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19 recommended

Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19
recommended